JPS62224286A - Method for producing enzyme by gene recombination mold and device therefor - Google Patents
Method for producing enzyme by gene recombination mold and device thereforInfo
- Publication number
- JPS62224286A JPS62224286A JP61067907A JP6790786A JPS62224286A JP S62224286 A JPS62224286 A JP S62224286A JP 61067907 A JP61067907 A JP 61067907A JP 6790786 A JP6790786 A JP 6790786A JP S62224286 A JPS62224286 A JP S62224286A
- Authority
- JP
- Japan
- Prior art keywords
- enzyme
- culture
- tank
- crp
- corepressor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 42
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 35
- 238000004519 manufacturing process Methods 0.000 title claims description 28
- 108090000623 proteins and genes Proteins 0.000 title abstract description 3
- 230000006798 recombination Effects 0.000 title description 2
- 238000005215 recombination Methods 0.000 title description 2
- 102000008169 Co-Repressor Proteins Human genes 0.000 claims abstract description 25
- 108010060434 Co-Repressor Proteins Proteins 0.000 claims abstract description 25
- 241000894006 Bacteria Species 0.000 claims description 12
- 108700005075 Regulator Genes Proteins 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract description 16
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract description 16
- 239000000919 ceramic Substances 0.000 abstract description 9
- 108010005774 beta-Galactosidase Proteins 0.000 abstract description 7
- 241000588724 Escherichia coli Species 0.000 abstract description 6
- 102000005936 beta-Galactosidase Human genes 0.000 abstract description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 2
- 150000001413 amino acids Chemical class 0.000 abstract description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 2
- 239000008103 glucose Substances 0.000 abstract description 2
- 239000000706 filtrate Substances 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 238000010586 diagram Methods 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 230000007423 decrease Effects 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 238000009295 crossflow filtration Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010037637 E coli beta-galactoside permease Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 238000011001 backwashing Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 108010085733 galactoside acetyltransferase Proteins 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 101150006320 trpR gene Proteins 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M21/00—Bioreactors or fermenters specially adapted for specific uses
- C12M21/14—Bioreactors or fermenters specially adapted for specific uses for producing enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/04—Filters; Permeable or porous membranes or plates, e.g. dialysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/18—External loop; Means for reintroduction of fermented biomass or liquid percolate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/10—Separation or concentration of fermentation products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
- C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は遺伝子組み換え菌による酵素生産方法及びその
方法に用いられる酵素生産装置に関し、特に酵素を大量
に生産するために用いられるものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to an enzyme production method using genetically modified bacteria and an enzyme production apparatus used in the method, and particularly to one used for producing enzymes in large quantities.
近年、遺伝子組み換え菌を用いた有用物質の生産が注目
されている。しかし、これら有用物質の生産は実験段階
に留まっているものが多く、大量生産可滝な段階には達
していない。In recent years, the production of useful substances using genetically modified bacteria has attracted attention. However, the production of these useful substances remains in the experimental stage in many cases and has not yet reached the stage where mass production is possible.
本発明は上記事情を考慮してなされたものであり、酵素
を大量に生産することができる遺伝子組み換え菌による
酵素生産方法及びこの方法に使用される酵素生産装置を
提供しようとするものである。The present invention has been made in consideration of the above circumstances, and aims to provide an enzyme production method using genetically modified bacteria that can produce enzymes in large quantities, and an enzyme production device used in this method.
本願第1の発明の直伝子組み換え菌による酵素生産方法
は、酵素遺伝子及びアポリプレッサーを生成する調節遺
伝子を導入した宿主菌を、コリプレッサーを含む培地を
用いて酵素生成を抑制した状態で培養した後、培養液か
ら前記コリプレッサーを除去するとともに、コリブレン
サーを含まない培地を用いて培養し、酵素を生産させる
ことを特徴とするものである。The enzyme production method using a directly genetically recombinant bacterium of the first invention of the present application involves culturing a host bacterium into which an enzyme gene and a regulatory gene for producing apolipressor have been introduced in a state in which enzyme production is suppressed using a medium containing a corepressor. After that, the corepressor is removed from the culture solution, and the culture is performed using a medium that does not contain the corepressor to produce the enzyme.
また、本願第2の発明の酵素生産装置は、酵素遺伝子及
びアポリプレッサーを生成するm!遺伝子を導入した宿
主菌を、コリプレッサーを含む培地を用いて培養する培
養槽と、該培養槽内の培養液を通過させて前記コリプレ
ッサーを除去する筒状のフィルターと、培養液を培養槽
からフィルターを通過ごせて循環させる循環系と、前記
培養槽にコリプレッサーを含まない培地を供給する培地
供給槽とを具備したことを特徴とするものである。Moreover, the enzyme production device of the second invention of the present application generates an enzyme gene and an apolipressor. A culture tank for culturing host bacteria into which a gene has been introduced using a medium containing a corepressor; a cylindrical filter for removing the corepressor by passing the culture solution in the culture tank; The invention is characterized by comprising a circulation system that circulates the medium through a filter, and a medium supply tank that supplies a corepressor-free medium to the culture tank.
酵素遺伝子及びアポリプレッサーを生成する調節遺伝子
を導入した宿主菌では、4A節遣仏子でアポリプレッサ
ーが生成される。本発明方法では初期には、この宿主菌
をコリプレッサーを含む培地を用いて培養するので、調
節遺伝子で生成されるアポリプレッサーがコリプレッサ
ーと結合してリプレッサーとなり、このリプレッサーが
酵素遺伝子のオペレータ部位に結合して転写を抑制する
。In host bacteria into which the enzyme gene and the regulatory gene that produces apolipressor are introduced, apolipressor is produced in the 4A setting. In the method of the present invention, the host fungus is initially cultured using a medium containing a corepressor, so apolipressor produced by the regulatory gene combines with the corepressor to become a repressor, and this repressor acts as a repressor for the enzyme gene. Binds to operator sites and represses transcription.
このため、ffj素の生産が抑制された状態で菌体が増
殖し、菌体数そのものは増加する。その後、培養液から
コリプレッサーを除去するとともに、コリプレッサーを
含まない培養液を用いて培養すると、宿主菌により酵素
が生産される。このように菌体数を増加させた後に酵素
を生成させるので、酵素の大量生産が可を駐となる。Therefore, the bacterial cells proliferate while the production of ffj element is suppressed, and the bacterial cell number itself increases. Thereafter, the corepressor is removed from the culture solution and culture is performed using a culture solution that does not contain the corepressor, so that the enzyme is produced by the host bacteria. Since enzymes are produced after increasing the number of bacterial cells in this way, mass production of enzymes becomes possible.
また、本発明の酵素生産装置は、培養槽、培養液からコ
リプレッサーを除去する手段となる筒状のフィルター及
び培養液の循環系ならびにコリプレッサーを含まない培
地を供給する培地供給槽を設けたものである。筒状のフ
ィルターではクロスフローロ過によりコリプレッサーが
迅速に除去されるので、h記の酵素生産方法を容易に適
用することができ、酵素生産の制御及び大量生産が可能
になる。Furthermore, the enzyme production apparatus of the present invention is provided with a culture tank, a cylindrical filter serving as a means for removing corepressors from the culture solution, a circulation system for the culture solution, and a medium supply tank for supplying a medium containing no corepressor. It is something. Since the corepressor is quickly removed by cross-flow filtration in a cylindrical filter, the enzyme production method described in section h can be easily applied, and enzyme production can be controlled and mass-produced.
以下、本発明をβ−ガラクトシダーゼの生産に適用した
実施例を図面を参照して説明する。Examples in which the present invention is applied to the production of β-galactosidase will be described below with reference to the drawings.
まず、遺伝子組み換え技術により、第3図に示すように
、トリプトファンプロモータtrpを含むプラスミドp
oc”r2に、β−ガラクトシダーゼ遺伝子lac Z
、β−ガラクトシドパーミアーゼ遺伝子1ac Y、ガ
ラクトシドトランスアセチラーゼ遺伝子Iac Aを導
入したプラスミドpMCT98を調製した。黒い矢印で
示す部位trpにはプロモータP、オペレータ0、アテ
ニュエータAtが存在する。First, by genetic recombination technology, a plasmid p containing the tryptophan promoter trp was created, as shown in Figure 3.
β-galactosidase gene lac Z in oc”r2
, β-galactoside permease gene lac Y, and galactoside transacetylase gene Iac A were introduced into plasmid pMCT98. Promoter P, operator 0, and attenuator At are present at the site trp indicated by the black arrow.
次に、pMC79BとアポリプL/−/サーtrp R
をクローン化したプラスミドpRLKl 3 (m4図
図示)とを金属イオンの共存下で、大腸菌C600内に
移植して形質転換した。Next, pMC79B and apolipL/-/trpR
The cloned plasmid pRLKl 3 (m4 diagram) was transplanted into Escherichia coli C600 for transformation in the presence of metal ions.
この形質転換された大腸菌C600では、コリプレッサ
ーであるトリプトファン
このトリプトファンがプラスミドpRLK 1 3の1
τpR部位で生成されるアポリプレッサーと結合してリ
プレッサーを生成し、このリプレッサーがプラスミドP
MCT98のtrp部位のオペレータに結合して転写が
抑制される.逆に、トリプトファンが存在しないと転写
が開始される.下記表に上記のようにして得られた大腸
菌C600を培養したときのトリプトファン濃度とβ−
ガラクトシダーゼの比活性との関係を示す.下記表から
明らかなように、トリプトファン濃度が高いほど、比活
性が低くなっている。In this transformed E. coli C600, tryptophan, which is a corepressor, is present in plasmid pRLK13.
It combines with the apolypressor produced at the τpR site to produce a repressor, and this repressor
It binds to the trp site operator of MCT98 and suppresses transcription. Conversely, transcription begins in the absence of tryptophan. The table below shows the tryptophan concentration and β-
The relationship with the specific activity of galactosidase is shown. As is clear from the table below, the higher the tryptophan concentration, the lower the specific activity.
1呵 −
この大腸菌を用いて、第1図に概略構成を示すPIIS
R生産装置によりβ−ガラクトシダーゼの生産を行なっ
た。まず、第1図図示の酵素生産装置について説明する
。第1図において、培養槽l中には上記のようにして得
られた遺伝子組み換え大腸菌C600の培養液2が収容
される。この培養液2は恒温槽3から送られる恒温水に
よって一定温度に維持される。クロスフロー口過を行な
う場合、この培養液2は配管4、ポンプ5及びポールバ
ルブ6を介装した配管7.流量計8ならびに入口配管9
を通ってフィルターケース10内に設けられたセラミッ
クフィルター11内を′m過する。1. - Using this E. coli, PIIS, the schematic structure of which is shown in Figure 1, was created.
β-galactosidase was produced using the R production apparatus. First, the enzyme production apparatus shown in FIG. 1 will be explained. In FIG. 1, a culture solution 2 of genetically recombinant E. coli C600 obtained as described above is contained in a culture tank 1. This culture solution 2 is maintained at a constant temperature by constant temperature water sent from a constant temperature bath 3. When performing cross-flow oral filtration, this culture solution 2 is passed through a pipe 7, which is equipped with a pipe 4, a pump 5, and a Pall valve 6. Flowmeter 8 and inlet piping 9
It passes through the ceramic filter 11 provided in the filter case 10.
このセラミックフィルター11を透過した口過液12は
電磁弁13を介装した口過液配管14を通って口過液槽
15に収容される。一方、菌体を含むclii液はポー
ルバルブ16を介装した出口配管17を通って培養槽l
に循環される。なお、配管4と配管7との間にはポンプ
5と並列して、ポールバルブ18を介装したバイパス配
管19が接続されている。また、入口配管9及び出口配
管17にはそれぞれ圧力計20.21が設けられている
。また1口過液配管14には、電磁弁22を介装した逆
洗用のガス供給配管23が接続されている。更に、培養
槽1には液面計24が設けられており、この液面計24
と連動するポンプ25により新しい培養液が口液間に合
わせて培地供給槽26から培養槽1へ供給される。The oral fluid 12 that has passed through the ceramic filter 11 passes through the oral fluid piping 14 having an electromagnetic valve 13 interposed therebetween, and is stored in the oral fluid tank 15 . On the other hand, the Clii liquid containing bacterial cells passes through the outlet pipe 17 with the Pall valve 16 interposed in the culture tank.
is circulated. Note that a bypass pipe 19 having a pole valve 18 interposed therebetween is connected in parallel with the pump 5 between the pipe 4 and the pipe 7. Moreover, pressure gauges 20 and 21 are provided in the inlet pipe 9 and the outlet pipe 17, respectively. Further, a gas supply pipe 23 for backwashing in which a solenoid valve 22 is interposed is connected to the one-port effluent pipe 14 . Furthermore, the culture tank 1 is provided with a liquid level gauge 24.
New culture solution is supplied from the culture medium supply tank 26 to the culture tank 1 by the pump 25 which is interlocked with the oral fluid.
前記セラミックフィルター11としては、第2図に示す
ものを用いた。このフィルター31は、全R750mm
で、6角柱形状のアルミナ製フィルタ一本体32の両端
にセラミックスシール33を取付け、これらの長手方向
に沿って直径4■の通過孔34を19個設けたものであ
り、有効口過面積は0.18m”である。なお、前記フ
ィルタ一本体32は通過孔34の膚囲で気孔径が徐々に
大きくなるような多層構造を有するもの(セラベールセ
ラミックフィルター:東芝セラミックス社製商品名)で
ある、また、各フィルターの通過孔に而するアルミナの
気孔径は0.2gmである。The ceramic filter 11 shown in FIG. 2 was used. This filter 31 has a total R750mm
Ceramic seals 33 are attached to both ends of a hexagonal prism-shaped alumina filter body 32, and 19 passage holes 34 with a diameter of 4 mm are provided along their longitudinal direction, and the effective opening area is 0. The filter main body 32 has a multilayer structure in which the pore diameter gradually increases around the passage hole 34 (Cerabel Ceramic Filter: a trade name manufactured by Toshiba Ceramics Co., Ltd.). Also, the pore diameter of the alumina in the passage holes of each filter was 0.2 gm.
L記酵素生産装置により、以下のようにしてβ−ガラク
トシダーゼを生産した。β-galactosidase was produced using the L enzyme production apparatus in the following manner.
まず、要求アミノ酸、炭素源となるグルコース及び濃度
100〜200μg/mlのトリプトファンを添加した
流加培養用培地を用い、37℃においてpH7で瀉加培
養を5時間行なった。First, using a fed-batch culture medium to which required amino acids, glucose as a carbon source, and tryptophan at a concentration of 100 to 200 μg/ml were added, the culture was carried out at 37° C. and pH 7 for 5 hours.
次に、培地供給槽26からトリプトファンを含まなl、
X以外は上記と同一組成の流加培養用培地を供給しなが
ら、培養槽l内の培養液2をポンプ6によりフィルター
11内を通過させて培養液からトリプトファンを除去し
、菌体を含む濃縮液は培養槽1へ循環させた。Next, l containing tryptophan from the medium supply tank 26,
While supplying a fed-batch culture medium with the same composition as above except for The solution was circulated to culture tank 1.
このときの培養時間と、トリプトファン濃度、菌体濁度
、β−ガラクトシダーゼの全活性及び比活性との関係を
第5図に示す、なお、第5図では口過開始時を破線で表
示する。また、第6図に口液量とトリプトファン濃度と
の関係を、第7図に培養時間と口過波束との関係をそれ
ぞれ示す。The relationship between the culture time, tryptophan concentration, bacterial cell turbidity, total activity and specific activity of β-galactosidase at this time is shown in FIG. 5. In FIG. 5, the time at which oral passage begins is indicated by a broken line. Furthermore, FIG. 6 shows the relationship between oral fluid volume and tryptophan concentration, and FIG. 7 shows the relationship between culture time and oral wave flux.
第5図から明らかなように、口過開始後、培養液中のト
リプトファン濃度は急激に減少している0口過開始直後
のトリプトファン濃度の減少の様子は第6図に示すよう
なものであり、迅速にトリプトファンを除去できること
がわかる。As is clear from Fig. 5, the tryptophan concentration in the culture solution decreases rapidly after the start of sips.The decrease in tryptophan concentration immediately after the start of sips is as shown in Fig. 6. It can be seen that tryptophan can be removed quickly.
また、第5図の菌体濁度の曲線は、口過開始直後を除い
ては、菌体が徐々に増殖していることを示している。た
だし、口過開始前の方が口過開始後よりも菌体の増加率
が大きくなっている。これは、口過開始前は酵素が生成
されず、菌体の増殖だけが行なわれるが、口過開始後は
トリプトファンが減少するので菌体が酵素を生成すると
ともに増炉しているものと考えられる。このことは、第
5図のβ−ガラクトシダーゼの全活性及び比活性の曲線
が、口過開始前は非常に低い値であるが、口過開始後は
急激に増加していることからもわかる。このように、酵
素生成を制御することができ、酵素の大量生産も可壱に
なる。Moreover, the curve of bacterial cell turbidity in FIG. 5 shows that the bacterial cells are gradually proliferating except immediately after the beginning of oral passage. However, the rate of increase in bacterial cells was greater before the start of oral congestion than after the initiation of oral congestion. This is thought to be due to the fact that before the start of filtration, enzymes are not produced and only bacterial cells proliferate, but after the start of filtration, tryptophan decreases, so the bacteria are producing enzymes and refurbishing. It will be done. This can be seen from the fact that the curves of the total activity and specific activity of β-galactosidase shown in FIG. 5 have very low values before the start of oral laxation, but rapidly increase after the initiation of oral laxation. In this way, enzyme production can be controlled and mass production of enzymes becomes possible.
また、第7図に示すように、口^流束は時間とともに徐
々に減少するが、逆洗間隔及び逆洗圧力を調整すること
により、口過波束をある程度回復できることがわかる。Moreover, as shown in FIG. 7, although the mouth flux gradually decreases with time, it is understood that the mouth flux can be recovered to some extent by adjusting the backwash interval and backwash pressure.
なお、L記実施例ではクロスフロー口過を行なうだめの
フCルターとして第2図に示すような19個の通過孔を
有するアルミナ製セラミックフィルターを用いたが、フ
ィルターは孔径のそろったものであれば材質は金属製や
合成樹脂製等何でもよく、また通過孔が1個あるいは複
数個でもよい。In Example L, an alumina ceramic filter having 19 passage holes as shown in Fig. 2 was used as a filter for cross-flow filtration, but the filter had uniform pore diameters. If so, it may be made of any material such as metal or synthetic resin, and may have one or more passage holes.
以上詳述した如く本発明によれば、酵素の生産を制御す
ることができ、しかも酵素の大量生産も可能になる等W
J著な効果を奏するものである。As detailed above, according to the present invention, enzyme production can be controlled, and mass production of enzymes is also possible.
It has a remarkable effect.
第1図は本発明の実施例における酵素生産装置の概略構
成図、第2図は同装置に用いられるフィルターを一8′
R破断して示す斜視図、第3図及び第4図はそれぞれ本
発明の実施例において大腸菌に移植されたプラスミドの
説明図、第5図は本発明の実施例で得られた培養時間と
、トリプトファン濃度、菌体濁度、酵素の全活性及び酵
素の比活性との関係を示す特性図、:56図は本発明の
実施例で得られた口液礒とトリプトファン濃度との関係
を示す特性図、第7図は本発明の実施例で得られた18
五時間と口過流束との関係を示す特性図である。
1・・・培養槽、2・・・培養液、3・・・恒温槽、4
,7・・・配管、5・・・ポンプ、6.16.18・・
・ポールバルブ、8・・・流1計、9・・・入口配管、
10・・・フィルターケース、11・・・セラミックフ
ィルター、12・・・口過液、13.22・・・電磁弁
、14・・・口過液配管、15・・・口過液槽、17・
・・出口配管、19・・・バイパス配管、20.21・
・・圧力計、23・・・ガス供給配管、24・・・液面
計、25・・・ポンプ、26・・・培地供給槽、31・
・・セラミックフィルター、32・・・フィルタ一本体
、33・・・セラミックスシール、34・・・通過孔。
出願人代理人 弁理士 鈴江 武彦
H:HindII+
R:Eco RT
7t3FEJ 第4図
4歩内fl(hr )
フ 5 口Figure 1 is a schematic configuration diagram of an enzyme production apparatus in an embodiment of the present invention, and Figure 2 shows a filter used in the apparatus.
3 and 4 are respectively explanatory diagrams of the plasmids transplanted into E. coli in the examples of the present invention, and FIG. 5 is the culture time obtained in the examples of the present invention, A characteristic diagram showing the relationship between tryptophan concentration, bacterial cell turbidity, total enzyme activity, and enzyme specific activity: Figure 56 is a characteristic diagram showing the relationship between oral fluid itching obtained in the example of the present invention and tryptophan concentration. Figure 7 shows the 18
FIG. 5 is a characteristic diagram showing the relationship between five hours and oral flux. 1...Culture tank, 2...Culture solution, 3...Thermostat, 4
, 7... Piping, 5... Pump, 6.16.18...
・Pole valve, 8...flow 1 meter, 9...inlet piping,
DESCRIPTION OF SYMBOLS 10... Filter case, 11... Ceramic filter, 12... Mouth filtration liquid, 13.22... Solenoid valve, 14... Mouth filtration liquid piping, 15... Mouth filtration tank, 17・
...Outlet piping, 19...Bypass piping, 20.21.
... Pressure gauge, 23 ... Gas supply piping, 24 ... Liquid level gauge, 25 ... Pump, 26 ... Culture medium supply tank, 31 ...
... Ceramic filter, 32... Filter body, 33... Ceramic seal, 34... Passing hole. Applicant's agent Patent attorney Takehiko Suzue H: HindII+ R: Eco RT 7t3FEJ Figure 4 4 steps fl (hr) F 5 mouths
Claims (2)
遺伝子を導入した宿主菌を、コリプレッサーを含む培地
を用いて酵素生成を抑制した状態で培養した後、培養液
から前記コリプレッサーを除去するとともに、コリプレ
ッサーを含まない培地を用いて培養し、酵素を生産させ
ることを特徴とする遺伝子組み換え菌による酵素生産方
法。(1) After culturing a host bacterium into which an enzyme gene and a regulatory gene for producing apolipressor have been introduced in a state in which enzyme production is suppressed using a medium containing a corepressor, the corepressor is removed from the culture solution, and A method for producing an enzyme using a genetically modified bacterium, which is characterized by producing the enzyme by culturing it in a medium that does not contain a corepressor.
遺伝子を導入した宿主菌を、コリプレッサーを含む培地
を用いて培養する培養槽と、該培養槽内の培養液を通過
させて前記コリプレッサーを除去する筒状のフィルター
と、培養液を前記培養槽からフィルターを通過させて循
環させる循環系と、前記培養槽にコリプレッサーを含ま
ない培地を供給する培地供給槽とを具備したことを特徴
とする酵素生産装置。(2) A culture tank in which a host bacterium into which an enzyme gene and a regulatory gene that produces apolipressor has been introduced is cultured using a medium containing a corepressor, and a culture solution in the culture tank is passed through to remove the corepressor. A cylindrical filter, a circulation system that circulates the culture solution from the culture tank through the filter, and a medium supply tank that supplies a corepressor-free medium to the culture tank. Enzyme production equipment.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61067907A JPH0775536B2 (en) | 1986-03-26 | 1986-03-26 | Enzyme production equipment using genetically modified bacteria |
GB8707130A GB2188324B (en) | 1986-03-26 | 1987-03-25 | Process for enzyme production with bacterium harboring recombinant plasmids. |
AU70659/87A AU600710B2 (en) | 1986-03-26 | 1987-03-26 | Process and apparatus for enzyme production with the bacterium harboring recombinant plasmids |
DE19873744928 DE3744928C2 (en) | 1986-03-26 | 1987-03-26 | Enzyme prodn. using bacterium contg. recombinant plasmids - using a host contg. enzyme genes and a control gene forming an apo-repressor |
DE19873709959 DE3709959A1 (en) | 1986-03-26 | 1987-03-26 | METHOD AND DEVICE FOR PRODUCING ENZYMS WITH A RECOMBINANT PLASMIDE-CONTAINING BACTERIUM |
GB8929030A GB2225789B (en) | 1986-03-26 | 1989-12-22 | Culture apparatus for enzyme production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61067907A JPH0775536B2 (en) | 1986-03-26 | 1986-03-26 | Enzyme production equipment using genetically modified bacteria |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62224286A true JPS62224286A (en) | 1987-10-02 |
JPH0775536B2 JPH0775536B2 (en) | 1995-08-16 |
Family
ID=13358439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61067907A Expired - Lifetime JPH0775536B2 (en) | 1986-03-26 | 1986-03-26 | Enzyme production equipment using genetically modified bacteria |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPH0775536B2 (en) |
AU (1) | AU600710B2 (en) |
DE (1) | DE3709959A1 (en) |
GB (2) | GB2188324B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4863617A (en) * | 1987-12-04 | 1989-09-05 | Toshiba Ceramics Co., Ltd. | Process and apparatus for separating solid-liquid compositions |
JP2015530110A (en) * | 2012-09-27 | 2015-10-15 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | Tangential flow perfusion system |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO305845B1 (en) | 1997-12-09 | 1999-08-02 | Kongsberg Offshore As | Anchoring mechanism for a guide post |
CN106497765B (en) * | 2016-11-24 | 2019-02-19 | 涡阳县华夏气体有限公司 | A kind of refined filtration equipment of industrial enzyme preparation |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58141796A (en) * | 1982-02-18 | 1983-08-23 | Kyowa Hakko Kogyo Co Ltd | Preparation of peptide |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA811368B (en) * | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
CA1338664C (en) * | 1985-04-10 | 1996-10-22 | Cetus Oncology Corporation | Recombinant hosts |
-
1986
- 1986-03-26 JP JP61067907A patent/JPH0775536B2/en not_active Expired - Lifetime
-
1987
- 1987-03-25 GB GB8707130A patent/GB2188324B/en not_active Expired - Fee Related
- 1987-03-26 AU AU70659/87A patent/AU600710B2/en not_active Ceased
- 1987-03-26 DE DE19873709959 patent/DE3709959A1/en active Granted
-
1989
- 1989-12-22 GB GB8929030A patent/GB2225789B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58141796A (en) * | 1982-02-18 | 1983-08-23 | Kyowa Hakko Kogyo Co Ltd | Preparation of peptide |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4863617A (en) * | 1987-12-04 | 1989-09-05 | Toshiba Ceramics Co., Ltd. | Process and apparatus for separating solid-liquid compositions |
JP2015530110A (en) * | 2012-09-27 | 2015-10-15 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | Tangential flow perfusion system |
Also Published As
Publication number | Publication date |
---|---|
DE3709959C2 (en) | 1991-04-25 |
AU600710B2 (en) | 1990-08-23 |
JPH0775536B2 (en) | 1995-08-16 |
GB2188324A (en) | 1987-09-30 |
DE3709959A1 (en) | 1987-10-08 |
GB2188324B (en) | 1990-12-05 |
GB8929030D0 (en) | 1990-02-28 |
GB2225789A (en) | 1990-06-13 |
GB2225789B (en) | 1990-09-12 |
GB8707130D0 (en) | 1987-04-29 |
AU7065987A (en) | 1987-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shimizu et al. | Filtration characteristics of hollow fiber microfiltration membranes used in membrane bioreactor for domestic wastewater treatment | |
JP3674705B2 (en) | Method for determining the occurrence of instability of dissolved oxygen in bacterial cell culture and fermenter used in the method | |
US4751003A (en) | Crossflow microfiltration process for the separation of biotechnologically produced materials | |
JPS62500356A (en) | Hollow fiber culture device and operating method with improved nutrient perfusion and product concentration | |
Matsumoto et al. | Cross-flow filtration of yeast by microporous ceramic membrane with backwashing | |
EP0196061B1 (en) | Method of controlling culture and apparatus therefor | |
CA2675183C (en) | Apparatus and methods for osmotically shocking cells | |
JP5989742B2 (en) | Method for controlling pH of liquid composition and target ion level | |
JPH022336A (en) | Continuous equipment of cell dispersion, culture and mass recovery | |
EP1907543A1 (en) | Production of recombinant products using capillary membranes | |
JPS62224286A (en) | Method for producing enzyme by gene recombination mold and device therefor | |
CN206418113U (en) | A kind of biological Membrance cuiture analogue reactor of water supply line | |
JPS6287086A (en) | Cultivation of genetic recombinant cell | |
JP2003510042A (en) | Cell culture method, membrane module, use of membrane module and reaction system for cell culture | |
US4948736A (en) | Continuous microorganism cultivating apparatus | |
JPS61192280A (en) | Apparatus for continuous cultivation of microorganism | |
JPS62138184A (en) | Apparatus for continuous culture of microorganism | |
JPS60259179A (en) | Cell culture tank and cell culture method | |
JP2521102B2 (en) | ▲ Ro ▼ Production method of useful gene product by overculture | |
JPS63237780A (en) | Filtration of bacillus subtilis | |
JPH02200176A (en) | Cell culture method and system therefor | |
JPH0787774B2 (en) | Bioreactor for adhesion-dependent cells | |
JPS60137276A (en) | Continuous brewing of vinegar | |
JPS61227779A (en) | Perfusion culture process | |
WO2021198281A1 (en) | Methods for producing plasmid dna |